Abstract

Introduction The dose tolerances of normal tissues continue being the main barrier in radiotherapy. To lower it, we recently proposed a novel concept: proton minibeam radiation therapy (pMBRT). It allies the inherent advantages of protons with the normal tissue preservation observed when irradiated with submillimetric spatially fractionated beams. The tumor receives a homogeneous dose distribution, while normal tissues benefit from the spatial fractionation of the dose. Purpose We have recently implemented this technique at the Orsay proton therapy clinical center. This work aims at optimizing the minibeam generation by means of a mechanical collimation. Materials and methods Monte Carlo simulations (GATEv7.1) were used to evaluate different irradiation configurations, e.g. collimator dimensions and materials (Brass, Tungsten, Iron and Nickel). Clinically relevant energies were used. Neutron contamination, Peak-to-valley dose ratios (PVDR) and beam penumbras were used as figures-of-merit. Results The neutron dose due to the minibeam collimator was found to be lower than 0.002% of the primary dose. A tungsten collimator provides the higher PVDR, but the generated neutron yield is 3 times higher than in other materials. Brass seems to provide the best compromise between PVDR values and neutron contamination. Conclusion A mechanical collimation only increases the biologic neutron dose by 0.04% of the peak surface dose therefore it is suitable for pMBRT. An optimized collimation for pMBRT, providing the best compromise between a high PVDR and low neutron generation, has been obtained.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call